Metabolic Dysfunction-Associated Steatohepatitis (MASH)
24 clinical trials · Condition
◉ Watch Metabolic Dysfunction-Associated Steatohepatitis (MASH)
| Record | Firm | Date |
|---|---|---|
| A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (NCT05395481) | Eli Lilly and Company | 2022-06-08 |
| New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) (NCT06647095) | General University Hospital, Prague | 2021-09-01 |
Track Metabolic Dysfunction-Associated Steatohepatitis (MASH) automatically
Every clearance here is in the API, with alerts when new ones post.